Effects of gangliosides on the functional recovery of damaged brain. 1984

G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe

The effect of GM1 ganglioside on the recovery of dopaminergic nigro-striatal neurons was studied in rats after unilateral hemitransection. GM1 treatment favoured the collateral sprouting of dopaminergic axons in the striatum as indicated by the induced increase of tyrosine hydroxylase (TH) activity and immunofluorescence. Concomitantly GM1 partially prevented the decrease of TH activity caused by the hemitransection in the substantia nigra ipsilateral to the lesion. A significant increase of TH immunoreactivity was also detected in the substantia nigra: GM1 prevented the disappearance of TH-positive cell bodies and increased the formation of TH-positive collaterals and dendrites with respect to the saline treatment. The addition of GM1 to embryonic dissociated mesencephalic cell cultures stimulates the expression of dopaminergic characteristics as suggested by the increase of 3H-DA uptake.

UI MeSH Term Description Entries
D009416 Nerve Regeneration Renewal or physiological repair of damaged nerve tissue. Nerve Tissue Regeneration,Nervous Tissue Regeneration,Neural Tissue Regeneration,Nerve Tissue Regenerations,Nervous Tissue Regenerations,Neural Tissue Regenerations,Regeneration, Nerve,Regeneration, Nerve Tissue,Regeneration, Nervous Tissue,Regeneration, Neural Tissue,Tissue Regeneration, Nerve,Tissue Regeneration, Nervous,Tissue Regeneration, Neural
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001930 Brain Injuries Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits. Brain Lacerations,Acute Brain Injuries,Brain Injuries, Acute,Brain Injuries, Focal,Focal Brain Injuries,Injuries, Acute Brain,Injuries, Brain,Acute Brain Injury,Brain Injury,Brain Injury, Acute,Brain Injury, Focal,Brain Laceration,Focal Brain Injury,Injuries, Focal Brain,Injury, Acute Brain,Injury, Brain,Injury, Focal Brain,Laceration, Brain,Lacerations, Brain
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005677 G(M1) Ganglioside A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis. GM1 Ganglioside,Monosialosyl Tetraglycosyl Ceramide,GM1a Monosialoganglioside,Ceramide, Monosialosyl Tetraglycosyl,Ganglioside, GM1,Monosialoganglioside, GM1a,Tetraglycosyl Ceramide, Monosialosyl
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe
January 1976, Advances in experimental medicine and biology,
G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe
June 1987, Neuroscience letters,
G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe
February 2006, Bulletin of experimental biology and medicine,
G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe
March 1961, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe
January 1961, Therapeutische Berichte,
G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe
January 1960, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe
March 1979, Biochemical pharmacology,
G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe
March 1979, Biochemical pharmacology,
G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe
February 1967, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
G Toffano, and G Savoini, and C Aldinio, and G Valenti, and R Dal Toso, and A Leon, and L Calza, and I Zini, and L F Agnati, and K Fuxe
August 2007, Experimental neurology,
Copied contents to your clipboard!